Skip to main content
logo
vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
30.92
-0.10 (-0.32%)
Jul 28, 2026, 1:55 PM EDT - Market open

vTv Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--1.02-2.024.01
Revenue Growth
-----49.61%-37.56%
Gross Profit
--1.02-2.024.01
Operating Income
-3.04-32.81-24.18-25.5-22.54-21.66
Net Income
2.25-26.97-18.46-20.25-19.16-12.99
Earnings Per Share
-0.93-3.20-3.20-9.71-9.98-8.29
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
98.0988.9336.759.4512.1313.42
Total Debt
000.170.530.720.93
Net Cash (Debt)
98.0988.9336.588.9211.4112.48
Net Cash Growth
217.08%143.14%310.19%-21.85%-8.60%158.34%
Net Cash Per Share
9.4110.566.344.285.947.97

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-10.41-25.26-25.31-19.08-16.02-19.31
Capital Expenditures
-----0.02-
Free Cash Flow
-10.41-25.26-25.31-19.08-16.04-19.31
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--100.00%-100.00%100.00%
Operating Margin
---2377.58%--1116.95%-540.87%
Pretax Margin
---2222.71%--1232.56%-439.85%
Profit Margin
---2232.55%--1242.47%-442.72%
FCF Margin
---2488.40%--795.00%-482.10%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
10.45-35.47-27.4016.63